Company Filing History:
2 out of 93 
1 out of 260 
Years Active: 2019-2025
Title: Jae-Eun Joo: Innovator in Pharmaceutical Chemistry
Introduction
Jae-Eun Joo is a prominent inventor based in Gyeonggi-do, South Korea. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target various diseases. With a total of 2 patents, her work is recognized for its potential impact on medical treatments.
Latest Patents
Jae-Eun Joo's latest patents include innovative compounds that have therapeutic applications. One of her notable inventions is a compound having a 1,2,3,4-tetrahydronaphthalene moiety or pharmaceutically acceptable salt thereof. This compound exhibits inhibitory activity against glucosylceramide synthase (GCS), making it useful for preventing or treating diseases such as Gaucher disease, Fabry disease, Tay-Sachs disease, and Parkinson's disease. Another significant patent is for a benzo[d]thiazole derivative or its pharmaceutically acceptable salt. This derivative selectively inhibits the protein-protein interaction between KRS and a laminin receptor, thereby inhibiting the migration of cancer cells. This invention holds promise for preventing or treating diseases associated with cancer cell metastasis.
Career Highlights
Throughout her career, Jae-Eun Joo has worked with reputable companies in the pharmaceutical industry. Notably, she has been associated with Yuhan Corporation and The Green Cross Corporation. Her experience in these organizations has contributed to her expertise in developing innovative pharmaceutical solutions.
Collaborations
Jae-Eun Joo has collaborated with several professionals in her field, including Eui-Chul Lee and Dong-Hoon Kim. These collaborations have likely enhanced her research and development efforts, leading to her successful patent applications.
Conclusion
Jae-Eun Joo is a distinguished inventor whose work in pharmaceutical chemistry has the potential to transform treatment options for various diseases. Her innovative patents reflect her commitment to advancing medical science and improving patient outcomes.